Don’t accept costs at face value, warn consumer groups
PETALING JAYA: Private hospital bills are no longer a total shot in the dark.
Malaysians can now check the typical price tag for 26 common procedures before committing to treatment, under a new industry-led price guide.
The guide released by the insurance and takaful industry is aimed at lifting the lid on medical costs but consumer groups cautioned that transparency should not become a rubber stamp for rising fees or normalising high prices.
The Malaysian Insurers and Takaful Operators (ITOs) in collaboration with industry associations – Life Insurance Association of Malaysia (Liam), Malaysian Takaful Association (MTA) and Persatuan Insurans Am Malaysia (Piam) – established a central medical claims data platform referred to as the “MHIT Database”.
“This initiative aims to facilitate the disclosure and publication of the price ranges of common healthcare services sought at private healthcare facilities in Malaysia,” the industry players said in the guideline published on the websites of insurance associations.
The price disclosure allows patients to compare costs and make informed decisions before receiving treatment, added the guideline.
Actual charges may differ depending on one’s medical needs, the healthcare provider and the type of treatment required.
However, insurance coverage remains subject to the terms and conditions of one’s policy.
The bill amount is presented in the form of the ‘Typical Bill Amount’ which refers to the median bill, where 50% of the patients are charged below the stated amount.
The rates given are for inpatient admissions where the length of the stay and daycare where the patient is discharged on the same day. The amount varies according to states and age groups.
For example, the typical bill amount for cataract surgery is RM8,400 for daycare admission.
The typical bill amount for an angiogram is RM11,700.
The removal of fibroid where inpatient admission is required will cost RM24,600.
Federation of Malaysian Consumers Associations (Fomca) secretary-general T. Saravanan said that while the publication of the price guide may appear helpful, it is important to emphasise that this is fundamentally an industry-driven initiative and consumers should approach it with caution.
“The data is derived from insurance and takaful claims, which are part of a profit-oriented private healthcare and insurance ecosystem. As such, the figures reflect what the market has already charged and paid, rather than what may be fair, reasonable or affordable for the average Malaysian.
“There is a real risk that industry-generated data could normalise high prices instead of questioning or correcting excessive charges that consumers have long complained about in the private healthcare sector,” he said.
Saravanan said consumers should not treat the price guide as a benchmark or endorsement of acceptable pricing.
“We should wait for official, independently verified data from the Health Ministry to ensure accuracy, reliability and fairness. The Health Ministry’s oversight is crucial to ensure that pricing information is grounded in medical necessity and public interest, not solely commercial considerations.
“In addition, any baseline recommendations on healthcare costs should ideally be guided by a neutral agency such as the Finance Ministry, to ensure pricing frameworks remain within the means of consumers and align with broader cost-of-living realities.
“Transparency must go hand in hand with strong governance, otherwise it risks becoming a tool that benefits industry players more than patients,” he added.
